Greenwich LifeSciences, Inc.
GLSI
$16.80
$0.422.56%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -10.67% | 45.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -29.76% | -27.93% | |||
| Operating Income | 29.76% | 27.93% | |||
| Income Before Tax | 30.20% | 28.60% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 30.20% | 28.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 30.20% | 28.60% | |||
| EBIT | 29.76% | 27.93% | |||
| EBITDA | 29.76% | 27.94% | |||
| EPS Basic | 30.46% | 31.61% | |||
| Normalized Basic EPS | 30.48% | 31.59% | |||
| EPS Diluted | 30.46% | 31.61% | |||
| Normalized Diluted EPS | 30.48% | 31.59% | |||
| Average Basic Shares Outstanding | 0.38% | 4.40% | |||
| Average Diluted Shares Outstanding | 0.38% | 4.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||